Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06472284

TetraGraph in Rocuronium Infusions

Train-of-four Monitoring Using the TetraGraph Neuromuscular Transmission Monitor to Evaluate Rocuronium Infusion Requirements During Major Neurosurgical and Surgical Procedures

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Joseph D. Tobias · Academic / Other
Sex
All
Age
28 Days – 18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

Conditions

Interventions

TypeNameDescription
DEVICETetraGraphetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.

Timeline

Start date
2024-09-12
Primary completion
2025-04-24
Completion
2026-02-01
First posted
2024-06-25
Last updated
2026-01-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06472284. Inclusion in this directory is not an endorsement.

TetraGraph in Rocuronium Infusions (NCT06472284) · Clinical Trials Directory